Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matthijs

Showing results (131-140 of 294) with videos related to

Pageof 30
Sort By:
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|December 18, 2012
IgM antibodies against apoptotic cells and phosphorylcholine in patients with acute myocardial infarction in relation to infarct size and inflammatory responseGwen M P Diepenhorst, Caroline L F Ciurana, Niubel Diaz Padilla, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2007
Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk studyZiad Mallat, Joelle Benessiano, Tabassome Simon, et al.
Heart (British Cardiac Society)|June 17, 2015
Habitual chocolate consumption and risk of cardiovascular disease among healthy men and womenChun Shing Kwok, S Matthijs Boekholdt, Marleen A H Lentjes, et al.
Journal of the American College of Cardiology|March 18, 2017
Lipoprotein(a) Improves Cardiovascular Risk Prediction Based on Established Risk AlgorithmsRutger Verbeek, Manjinder S Sandhu, G Kees Hovingh, et al.
Circulation|November 13, 2002
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteersNick R Bijsterveld, Arno H Moons, S Matthijs Boekholdt, et al.
The American Journal of Cardiology|May 10, 2011
Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study)Mélanie Côté, Amélie Cartier, Anne Q Reuwer, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 30, 2023
Dobutamine stress echocardiography during transcatheter edge-to-edge mitral valve repair predicts residual mitral regurgitationFrank Meijerink, Marja Holierook, Susanne Eberl, et al.
Journal of Lipid Research|September 4, 2012
Relationship between atorvastatin dose and the harm caused by torcetrapibPhilip J Barter, Kerry-Anne Rye, Mohan S Beltangady, et al.
Journal of the American College of Cardiology|February 2, 2010
Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and womenBenoit J Arsenault, Jamal S Rana, Erik S G Stroes, et al.
European Journal of Preventive Cardiology|February 6, 2025
The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk studyJordan M Kraaijenhof, Marije J Kerkvliet, Nick S Nurmohamed, et al.
Pageof 30

Showing results (131-140 of 294) with videos related to

Sort By:
Pageof 30
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|December 18, 2012
IgM antibodies against apoptotic cells and phosphorylcholine in patients with acute myocardial infarction in relation to infarct size and inflammatory responseGwen M P Diepenhorst, Caroline L F Ciurana, Niubel Diaz Padilla, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2007
Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk studyZiad Mallat, Joelle Benessiano, Tabassome Simon, et al.
Heart (British Cardiac Society)|June 17, 2015
Habitual chocolate consumption and risk of cardiovascular disease among healthy men and womenChun Shing Kwok, S Matthijs Boekholdt, Marleen A H Lentjes, et al.
Journal of the American College of Cardiology|March 18, 2017
Lipoprotein(a) Improves Cardiovascular Risk Prediction Based on Established Risk AlgorithmsRutger Verbeek, Manjinder S Sandhu, G Kees Hovingh, et al.
Circulation|November 13, 2002
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteersNick R Bijsterveld, Arno H Moons, S Matthijs Boekholdt, et al.
The American Journal of Cardiology|May 10, 2011
Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study)Mélanie Côté, Amélie Cartier, Anne Q Reuwer, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 30, 2023
Dobutamine stress echocardiography during transcatheter edge-to-edge mitral valve repair predicts residual mitral regurgitationFrank Meijerink, Marja Holierook, Susanne Eberl, et al.
Journal of Lipid Research|September 4, 2012
Relationship between atorvastatin dose and the harm caused by torcetrapibPhilip J Barter, Kerry-Anne Rye, Mohan S Beltangady, et al.
Journal of the American College of Cardiology|February 2, 2010
Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and womenBenoit J Arsenault, Jamal S Rana, Erik S G Stroes, et al.
European Journal of Preventive Cardiology|February 6, 2025
The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk studyJordan M Kraaijenhof, Marije J Kerkvliet, Nick S Nurmohamed, et al.
Pageof 30